19-14516113-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_006145.3(DNAJB1):c.850G>A(p.Val284Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000465 in 1,613,726 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006145.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAJB1 | NM_006145.3 | c.850G>A | p.Val284Ile | missense_variant | 3/3 | ENST00000254322.3 | NP_006136.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAJB1 | ENST00000254322.3 | c.850G>A | p.Val284Ile | missense_variant | 3/3 | 1 | NM_006145.3 | ENSP00000254322 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000986 AC: 15AN: 152146Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000518 AC: 13AN: 250906Hom.: 0 AF XY: 0.0000368 AC XY: 5AN XY: 135702
GnomAD4 exome AF: 0.0000390 AC: 57AN: 1461462Hom.: 0 Cov.: 32 AF XY: 0.0000303 AC XY: 22AN XY: 727084
GnomAD4 genome AF: 0.000118 AC: 18AN: 152264Hom.: 0 Cov.: 32 AF XY: 0.000134 AC XY: 10AN XY: 74462
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 03, 2023 | The c.850G>A (p.V284I) alteration is located in exon 3 (coding exon 3) of the DNAJB1 gene. This alteration results from a G to A substitution at nucleotide position 850, causing the valine (V) at amino acid position 284 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at